[18F]Fluoroestradiol (FES) PET/CT

DRUG2 trials

Sponsors

University of Utah

Conditions

Estrogen Receptor Positive Breast CancerInvasive Lobular Breast Carcinoma

Early Phase 1

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

TerminatedNCT04727632

University of UtahEstrogen Receptor Positive Breast Cancer

Start: 2021-03-31End: 2024-07-30Updated: 2024-10-28

Phase 2

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

TerminatedNCT04252859

University of UtahInvasive Lobular Breast Carcinoma

Start: 2020-12-11End: 2024-12-07Updated: 2025-05-18

Related Papers

Prospective Pilot Study of <sup>18</sup>F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas

American Journal of Roentgenology2023-03-1626 citations